Penserra Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.28 - $19.53 $10,924 - $14,940	-765 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $129 - $204	10 Added 1.32%	765 $11,000
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $77 - $122	5 Added 0.67%	755 $15,000
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $289 - $566	-15 Reduced 1.96%	750 $17,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $11,823 - $20,513	483 Added 171.28%	765 $18,000

Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $11,023 - $15,070	282 New	282 $11,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.